Treatment with MG132, the inhibitor of proteasome, restored the pVHL level comparable to HCC cells without shOTUD6B treatment (Figure 3D; Figure S3F, Supporting Information), indicating that the pVHL was undergoing proteasome‐dependent degradation in HCC cells with OTUD6B knockdown. Here, OTUD6B is linked to hepatocellular carcinoma.